tiprankstipranks
Advertisement
Advertisement
AbCellera Biologics call volume above normal and directionally bullish
PremiumThe FlyAbCellera Biologics call volume above normal and directionally bullish
17d ago
AbCellera, Jazz Partner on Next-Generation Cancer Antibodies
Premium
Company Announcements
AbCellera, Jazz Partner on Next-Generation Cancer Antibodies
24d ago
Jazz Pharmaceuticals, AbCellera collaborate for TCE multispecific antibodies
Premium
The Fly
Jazz Pharmaceuticals, AbCellera collaborate for TCE multispecific antibodies
24d ago
AbCellera appoints Victor Sandor to board of directors
PremiumThe FlyAbCellera appoints Victor Sandor to board of directors
1M ago
Largest borrow rate increases among liquid names
Premium
The Fly
Largest borrow rate increases among liquid names
2M ago
AbCellera Biologics Bets Big on 2026 Trial Catalysts
Premium
Company Announcements
AbCellera Biologics Bets Big on 2026 Trial Catalysts
2M ago
ABCL Earnings Report this Week: Is It a Buy, Ahead of Earnings?
PremiumPre-EarningsABCL Earnings Report this Week: Is It a Buy, Ahead of Earnings?
2M ago
AbCellera initiated with an Overweight at Cantor Fitzgerald
Premium
The Fly
AbCellera initiated with an Overweight at Cantor Fitzgerald
2M ago
AbCellera: Strategic Pivot to an Internal Pipeline and Key ABCL635 Readouts Position Shares for Multibillion-Dollar Upside
Premium
Ratings
AbCellera: Strategic Pivot to an Internal Pipeline and Key ABCL635 Readouts Position Shares for Multibillion-Dollar Upside
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100